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Probiotic bacteria prevent Salmonella –
induced suppression of lymphoproliferation
in mice by an immunomodulatory
mechanism
R. Doug Wagner* and Shemedia J. Johnson
Abstract
Background: Salmonella enterica infections often exhibit a form of immune evasion. We previously observed that
probiotic bacteria could prevent inhibition of lymphoproliferation and apoptosis responses of T cells associated
with S. enterica infections in orally challenged mice.
Results: In this study, changes in expression of genes related to lymphocyte activation in mucosa-associated
lymphoid tissues (MALT) of mice orally infected with S. enterica with and without treatment with probiotic bacteria
were evaluated. Probiotic bacteria increased expression of mRNA for clusters of differentiation antigen 2 (Cd2),
protein tyrosine phosphatase receptor type C (Ptprc), and Toll-like receptor 6 (Tlr6) genes related to T and B cell
activation in mouse intestinal tissue. The probiotic bacteria were also associated with reduced mRNA expression
of a group of genes (RelB, Myd88, Iκκa, Jun, Irak2) related to nuclear factor of kappa light chains enhancer in B cells
(NF-κB) signal transduction pathway-regulated cytokine responses. Probiotic bacteria were also associated with
reduced mRNA expression of apoptotic genes (Casp2, Casp12, Dad1, Akt1, Bad) that suggest high avidity
lymphocyte sparing. Reduced CD2 immunostaining in mesenteric lymph nodes (MLN) was suggestive of reduced
lymphocyte activation in probiotic-treated mice. Reduced immunostaining of TLR6 in MALT of probiotic-treated, S.
enterica-infected mice suggests that diminished innate immune sensitivity to S. enterica antigens is associated with
preventing lymphocyte deletion.
Conclusions: The results of this study are consistent with prevention of S. enterica-induced deletion of lymphocytes
by the influence of probiotic bacteria in mucosal lymphoid tissues of mice.
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Background
Salmonella enterica is known to evade host defenses and
induce persistent infections [1]. Salmonella sp. persist-
ence is also aided by a virulence mechanism that causes
clonal deletion of high-avidity CD4+ T cells [2]. Further-
more, Salmonella sp. induces an inflammatory response
and secretes a factor that blocks macrophage and den-
dritic cell migration [3]. The intestinal microbiota can
modulate the pathogenesis and host evasion mechanisms
of S. enterica; for example, commensal E. coli improved
the host response to Salmonella sp. infection by an im-
mune system regulatory effect [4]. The mechanisms of
mucosal immune system regulation are only partially
understood and the roles of microbes in this regulation
are even less well understood. Addition of probiotic bac-
teria to the indigenous intestinal microbiota also affects
mucosal immune regulation.
In a previous study, we observed that bacteria from a
commercial probiotic product modified the host im-
mune response to S. enterica by enhancing the prolifera-
tive response of spleen lymphocytes to S. enterica
antigens. We also observed that the T and B cell
enriched splenocyte fractions had reduced activities of
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apoptosis-related cysteine peptidase or caspase (CASP) 3
and CASP7 [5]. Caspases are involved in the signaling
pathway that directs programmed cell death (apoptosis) in
activated immune cells. These results were observed in
mice that were not previously immunized to S. enterica,
suggesting that the innate pathways of immune activation
were involved. T cells that have been activated, but lacking
secondary signals, activate an intrinsic caspase pathway
that is arrested by signals from B- cell CLL/lymphoma 2
(BCL) 2 and its related proteins. The probiotic bacteria
may be providing analogs to these secondary signals that
maintain the survival of activated lymphocytes.
The present study sought to determine whether the
secondary signals are mediated by intermediary antigen-
presenting cells (APC), such as dendritic cells and intes-
tinal epithelial cells or by direct contact to lymphocytes.
APC would signal to lymphocytes with cytokines to
affect a change in their activation and apoptotic status.
Expression of these and other signaling molecules in
mucosal tissues of probiotic-treated and untreated S.
enterica-infected mice were compared. A direct T cell
response to microbial antigens would have to occur by a
yet unrevealed mechanism or possibly by the same path-
ways that function in the APC. Intestinal epithelial cells
are also involved in T cell activation by production of
pro-inflammatory cytokines in the presence of com-
mensal or probiotic bacteria [6].
Methods
Microorganisms
A blend of bacteria derived from a commercial probiotic
product, which contained: Lactobacillus reuteri, Lactoba-
cillus rhamnosus, Lactobacillus acidophilus, Lactobacillus
casei, Lactobacillus gasseri, Bifidobacterium thermophilus,
Bifidobacterium longum, and Bifidobacterium adolescentis
was used, as previously described [5]. These isolates are
available from the corresponding author upon reasonable
request. The products were cultured for isolation of
component bacteria on de Man Rogosa Sharpe (MRS)
agar (REMEL Laboratories) and Bifidobacterium agars
(Anaerobe Systems) incubated anaerobically for 48 h at
37 °C. Bacterial isolates were identified by their cellular
fatty acid methyl ester compositions (Microbial ID, Inc.)
and by their 16S rRNA sequences with the MicroSeq 16S
rRNA sequence assays (Applied Biosystems, Inc.). Rapid
identifications were made with the Biolog Microbial Iden-
tification System. Serial dilution plate counts on MRS or
Bifidobacterium agar were used to quantify the compo-
nents of the probiotic products. Probiotic products were
suspended in drinking water at a concentration of 5 ×
106 CFU/mouse and administered to mice with a feeding
tube, as previously described [5]. Salmonella enterica
Serotype Cubana, originally isolated from poultry [5] was
grown on Trypticase Soy agar with 5% sheep blood
(REMEL) or in Trypticase Soy broth at 37 °C in an atmos-
phere of 5% CO2 and air. The Salmonella isolate was
originally characterized as Serotype Typhimurium and
subsequently determined to be serotype G2 (serovar
Cubana) by the Arkansas Regional Laboratory of the Food
and Drug Administration (FDA), Jefferson, AR. The
isolate is available upon reasonable request from the
corresponding author.
Mice
A total of 4 male and 4 female 8 week-old human
microbiota-associated [5] and 4 male and 4 female 8
week-old defined-microbiota BALB/c mice (Charles
River) were used in this study with the approval of the
Institutional Animal Care and Use Committee of the
National Center for Toxicological Research. Sterile water
and NIH-31 mouse chow (Purina) were supplied ad
libitum to the mice. The probiotic bacteria were admin-
istered with a feeding tube to mice 7 days before oral
challenge with S. enterica. Isolator sterility was assessed
with weekly swab cultures on Trypticase soy blood agar
plates (REMEL). The cultures were incubated at 37 °C in
95% air, 5% CO2 atmosphere overnight and the plates
were assessed for bacterial growth. The mice were fed a
NIH-31 diet sterilized in the transfer box as previously
described [5].
Experimental design
Control mice were human microbiota-associated in our
laboratory, as previously described [5] or specific patho-
gen free from the vendor and fecal samples were
cultured to assure their status. Treatment mice were col-
onized with the probiotic bacteria blend and fecal sam-
ples were collected from the mice 1 day later to culture
for the presence of the probiotic bacteria. At 7 days after
probiotic treatment, 4 probiotic-treated mice and 4 un-
treated mice were each orally inoculated with 2 × 108
colony forming units (CFU) of Salmonella enterica using
a feeding tube. Seven days later, the mice were eutha-
nized and MALT consisting of intestinal lamina propria,
Peyer’s patches, and mesenteric lymph nodes were
excised for analysis. Spleen cells were isolated and incu-
bated with S. enterica antigens and mitogens to evaluate
lymphoproliferative effects, as previously described [5].
Total RNA samples were extracted from the tissues and
cDNA were generated, from which quantitative real-
time-polymerase chain reaction (qRT-PCR) analyses
were run to quantify mRNA expressed from genes of the
mucosal immune system in probiotic-treated and un-
treated mice. The data were analyzed to identify cell type
markers and intracellular signaling molecules involved
in the host response to S. enterica that were affected by
the probiotic bacteria. Control mice and probiotic-
bacteria-treated BALB/c mice were orally challenged
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with S. enterica and pathway-focused gene expression pro-
files were generated from qRT-PCR expression arrays, as
described below, to compare signal transduction in MALT
from defined-microbiota mice treated with or without
probiotic bacteria and orally challenged with S. enterica.
The experiment was repeated on a group of 8 specific
pathogen free mice to obtain intestinal lamina propria,
Peyer’s patches, and mesenteric lymph nodes for immu-
nolocalization by an immunohistochemical method
using antibodies from Santa Cruz Biotechnology. Immu-
nolocalization of CD21+ B cells and dendritic cells, CD2
+ T lymphocytes, and detection of PTPRC, TLR6, and v-
rel avian reticuloendotheliosis viral oncogene homolog B
(RELB) cellular expression was used to evaluate the pro-
biotic effects that were observed on mRNA expression.
Antigen preparations
Antigens were prepared from crude lysates of S. enterica
for in vitro activation and apoptosis assays of lympho-
cytes collected from the spleens of mice from the experi-
ments, as previously described [5]. Briefly, the entire
volume of a 500 ml log phase broth culture of bacteria
was centrifuged at 2000 × g for 15 min. The bacterial
pellet was washed three times with an equal volume of
PBS and centrifuged again. The final bacterial pellet was
suspended in 10 ml of PBS and passed through a French
pressure cell (SLM/AMINCO) at 15,000 lb./in2 to
disrupt the bacteria. The disrupted bacteria were centri-
fuged at 2000 × g and the protein content of the super-
natant was determined by the bicinchoninic acid protein
assay (Pierce Chemical Co.) to express antigen mass as
mg protein, and used as the antigens for lymphocyte
proliferation assays.
Lymphocyte proliferation assay
Lymphocytes from the spleens of mice treated with pro-
biotics after S. enterica challenge were assayed for prolif-
erative responses to S. enterica antigens, as previously
described [5]. Lymphocyte proliferation assays were per-
formed with the CellTiter Aqueous 96 assay (Promega,
Corp.). Lymphocytes from the spleens of experimentally
treated mice were prepared and incubated at a density of
5 × 105 cells/well of a 96-well culture plate in RPMI
medium (Thermo Fisher Scientific, Inc.) containing S.
enterica antigens. Antigens were added to 3 wells with
spleen cells at a concentration of 10 μg whole cell lysate
protein antigen preparation per well. Antigens were in-
cubated with the cells 56 h at 37 °C in a humidified 5%
CO2 incubator before testing for lymphocyte prolifera-
tion. The formation of proliferating clonal clusters was
also verified microscopically. The proliferation of lym-
phocytes in response to the antigens was measured as
absorbance of reduced 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfonyl)-2H–tetrazolium,
inner salt (MTS) at 490 nm, which was measured with a
plate reader (Applied Biosystems). The average of three
wells per sample was used to determine the mean ± stand-
ard error of the mean (SEM) Abs490 for three mice per
group. Proliferative responses of lymphocytes to antigens
were compared as % increases in MTS absorbance as a
result of the effects of probiotics.
Apoptosis assay
Lymphocytes from the spleens of the mice 7 days after
probiotic treatment and S. enterica challenge were
analyzed for activation of caspases 3 and 7 (Apo-ONE,
Promega Corp.). Each assay well of a Nunc F16 black
Maxisorp 96 well fluorescent assay plate (Thermo Fisher
Scientific, Inc.) contained 50 μl of cell suspension in
Roswell Park Memorial Institute (RPMI) 1640 medium at
a cell concentration of 2 × 105 cells/ml to which was
added 10 μg antigen preparation per well. After 56 h incu-
bation at 37 °C in a humidified 5% CO2 incubator, 100 μl
of working substrate solution was added to each well. The
plate was rotated at 300 rpm for 30 min at room
temperature. Fluorescence intensities were measured in a
plate reader (Applied Biosystems) set with filters for an ex-
citation wavelength of 485 nm and an emission wave-
length of 530 nm at 30 min intervals until the rates of
increase reached a plateau state. Endpoint fluorescence in-
tensities from each treatment group were compared as the
% change in relative fluorescence intensities resulting from
probiotic inhibition of CASP3/7activation.
qRT-PCR array profiling of signaling pathway and
cytokine genes
RT2 Profiler™ PCR arrays from Qiagen Bioscience were
used to assess expression of mRNA for 327 genes in-
volved in the host response to bacteria in the mucosal
immune tissues of the mouse GI tract. Arrays for genes
involved in apoptosis (PAMM-012 Mouse Apoptosis
Array), for genes involved in NF-κB activation (PAMM-
025 Mouse NF-κB Array), and for mouse T and B cell
activation markers (PAMM-053) were used according to
the manufacturer’s instructions. Total cellular RNA from
Peyer’s patches, mesenteric lymph nodes, and lamina
propria from 8 mice were isolated using ArrayGrade
total RNA isolation kits (Qiagen, Inc.). The RNA sam-
ples were treated with DNAse-1 (Thermo Fisher Scien-
tific, Inc.) reverse-transcribed with the RT2 PCR Array
first strand kit and the resulting cDNA was analyzed by
real-time PCR for detection in a BioRad Pci,Q5 instru-
ment. The housekeeping genes used in the study were:
beta glucuronidase, hypoxanthine phosphoribosyltransfer-
ase 1, heat shock protein 90 alpha family class B member
1, glyceraldehyde-3-phophate dehydrogenase, and beta
actin. Results of the PCR array experiment were analyzed
with the Excel™ (Microsoft Corp.) template provided by
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Qiagen, Inc. to determine the key signal transduction
pathways and immune system cells involved in the pro-
biotic effects.
Immunolocalization of responses to probiotic bacteria in
the murine MALT
The gene expression profiling was used to indicate specific
mouse immune system genes that respond to the effect of
probiotic bacteria in response to S. enterica. Two-color
immunohistochemistry was used to determine the cell
types involved with specific gene product markers and
their tissue locations. Toxicologic Pathology Associates
(Jefferson, Arkansas) prepared frozen sections of the
MALT tissues from 8 mice and conducted the immunolo-
calization on those sections for cell markers and specific
intracellular signal transduction gene products. Antibodies
labelled with horseradish peroxidase specific for CD21,
CD2, PTPRC, TLR6, and RELB were purchased from
Santa Cruz Biologics. Densitometry of the stained areas in
Peyer’s patches, lamina propria of intestinal villi, or the
cortical and paracortical regions of mesenteric lymph
nodes were measured by the Positive Pixel Count Algo-
rithm from Aperio Technologies (Leica Biosystems).
Analysis of data
Evaluation of statistically significant differences between
the results from treatment groups and control groups
were determined with Repeated Measures Analysis of
Variance and Bonferroni’s post tests using Prism v.6.0
software (GraphPad Software). Numerical count data
were log10 transformed prior to statistical analysis to
make the data better fit a normal distribution. Statistical
significance was defined at P < 0.05.
Results
Persistence of probiotic bacteria and Salmonella sp. in the
murine GI tracts
In our previous study [5], colonization of germfree mice
by probiotic bacteria was easily verified by microbial cul-
ture from feces, but the mice in this study had conven-
tional microbiota. The presence of L. reuteri, which is
not a component of the BALB/c mouse colony micro-
biota (Charles River) in the defined-microbiota mice in
the present study was confirmed by culture on MRS agar
and microbial identification of colonies from feces at
7 days after oral feeding of 8.0 log10 CFU of the pro-
biotic bacterial mixture. Infection of mice was confirmed
by recovery of S. enterica from the mice 7 days after oral
challenge (Table 1).
S. enterica was recovered from one of the probiotic-
fed mice, and all of the control mice 7 days after oral
Salmonella challenge. Table 1 also shows numbers of
lactic acid bacteria that were recovered from mice 7 days
after oral S. enterica challenge and grown on MRS agar.
Probiotic bacteria prevented immunosuppression of T
cells in mice to S. enterica antigens
Lymphocytes from the spleens of BALB/c mice chal-
lenged with S. enterica only for 7 days did not proliferate
in response to the B-cell mitogen lipopolysaccharide
(LPS) or to the T cell mitogen concanavalin-A, nor did
they respond to soluble antigens from S. enterica (Fig.
1a). This lack of responsiveness was observed under
similar conditions in our previous report [5]. Decreased
lymphoproliferation of splenocytes in mice treated with
probiotics was observed in the control treatment and
LPS treatment groups. Splenocytes from mice that were
fed the mixture of probiotic bacteria prior to S. enterica
challenge had significant proliferative responses to
concanavalin-A and the S. enterica antigens (Fig. 1a),
showing a preventative effect of the probiotic bacteria
on S. enterica-induced immunosuppression. The lym-
phoproliferative responses to S. enterica LPS were not
significantly changed by probiotic bacteria compared
with the S. enterica-treated control mice.
The probiotic bacteria altered the activation of cellular
apoptosis in lymphocytes, as reported previously [5]. In
the present study, activation of CASP3 and CASP7,
which mediate lymphocyte apoptosis, was significantly
increased in S. enterica-infected BALB/c mice, compared
to the response to LPS or concanavalin-A, but was
strongly induced by S. enterica antigens (Fig. 1b). The
mice that were fed probiotic bacteria before S. enterica
challenge did not have a significant increase in lympho-
cyte CASP3 and CASP7 activation by S. enterica anti-
gens (Fig. 1b), which suggests that strong S. enterica
induction of T cell apoptotic responses was suppressed
by the probiotics.
Table 1 Numbers of bacteria recovered from experimental
mice




1 - 2.2 × 106 5.0 × 1010
2 - 6.7 × 106 3.3 × 1010
3 - 1.6 × 107 4.8 × 1010
4 - 2.8 × 106 4.2 × 1010
5 + 0 6.9 × 1011
6 + 0 4.2 × 1011
7 + 0 4.4 × 1011
8 + 7.6 × 106 5.2 × 1011
aMice 1–4 were non-treated with probiotic lactic acid bacteria. Mice 5–8 were
orally challenged with 1 × 108 CFU probiotic bacteria mixture. Seven days
later, all mice were orally challenged with 1 × 108 CFU/mL S. enterica. bThe
number of S. enterica isolated from feces of mice 7 days after challenge were
enumerated on SS agar plates. cThe numbers of lactic acid bacteria were
enumerated on MRS agar plates and reported as CFU/g feces 7 days after S.
enterica challenge
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Probiotic bacteria altered mRNA expression of genes
involved in responses to S. enterica infection
The presence of probiotic bacteria induced changes in
expression of immune response genes and cellular lo-
cations in the MALT of mice infected with S. enter-
ica. There was a general increase in T cell function
and a decrease in inflammatory responses, as evi-
denced by increased expression of T cell activation
genes and apoptosis-related genes and decreased gene
expression of NF-κB signal transduction pathway
components and proinflammatory cytokines, respect-
ively (Table 2). Probiotic lactobacilli had significant
effects on the expression of mRNA from genes in-
volved in B and T cell activation, signal transduction
by the NF-κB pathway, and apoptosis, when the mice
were challenged with S. enterica. Expression of the
mRNA for the lymphokines interleukin (IL) -12 p40
(Il12p40) and Il4 were reduced, while Il10 mRNA was
significantly increased by the presence of probiotic
lactobacilli (Table 2). Other genes involved in
lymphocyte activation were also affected by probiotic
bacteria. Nearly 3-fold induction of mRNA for Cd2,
and Ptprc genes (Table 2) indicates activation and dif-
ferentiation of B and T cells. Other components of
the T and B cell activation signal-transduction path-
ways were also induced (Table 2). Since activated
splenocytes proliferated in response to concanavalin-
A, but not Salmonella LPS (Fig. 1a), it appears that
mostly T cell activation accounts for the increased ex-
pression of the lymphocyte activation genes listed in
Table 2. This conclusion is supported by the result
that expression of the mRNA for Tlr4, the protein of
which is a receptor for S. enterica lipopolysaccharides
on APC, was not affected by probiotic bacteria (Table
2). Decreased expression of Tlr1 and increased ex-
pression of Tlr6 in MALT suggests that probiotic bac-
teria modified the spectrum of bacterial lipoproteins
that could be detected by APC in the MALT. RNA
for Cd21 was not detected in the S. enterica chal-
lenged mice that were not treated with probiotic bac-
teria. It was present in samples of MALT from the
probiotic-treated mice, consistent with the possibility
that probiotics prevented the loss of antigen-specific
lymphocytes at sites of infection.
Additional effects of the probiotic lactobacilli were ob-
served in genes that relate to the NF-κB signal transduc-
tion pathway that controls expression of cytokine genes in
response to receptor detection of microbial antigens.
mRNA expression of several signaling protein genes
CASP8 and FADD like apoptosis regulator (Cflar), Casp8,
receptor TNFRSF-interacting serine threonine kinase 1
(Ripk1), TNF receptor associated factor 2 (Traf2), Bcl10,
and Bcl2) was slightly reduced, but not to the 2-fold
change level of significance (Table 2). Significant reduction
(P < 0.05) in mRNA expression of RelB, myeloid differen-
tiation primary response gene 88 (Myd88), ring finger pro-
tein 7 (Rnf7), inhibitor of light polypeptide gene enhancer
in B cell kinase alpha (Iκκα), and Map/Erk kinase kinase
(Mekk) are indicative of a response that suppresses trans-
duction of proinflammatory signals in lymphocytes (Table
2). The increased mRNA expression of interleukin-1
receptor-associated kinase 2 (Irak2) and v-jun sarcoma
virus 17 oncogene homolog (Jun) induced by probiotic
bacteria in Table 2 suggest differential regulation of these
genes that may function simultaneously in other signal
transduction pathways.
Activation of T and B lymphocytes to produce cytokines
is linked to activation of programmed cell death responses
in these cells. In this study, expression of mRNA for genes
involved in apoptosis was reduced by the presence of pro-
biotic bacteria (Table 2). Multiple signaling pathways of
apoptosis induction and suppression function simultan-
eously to regulate this important process. We observed
that probiotic bacteria were associated with suppression of
a b
Fig. 1 Lymphocyte proliferation and apoptosis responses. Proliferation of splenocytes from uninfected mice (Mice), S. enterica-infected BALB/c
mice (Ctrl), or S. enterica-infected, probiotic-treated mice to LPS (LPS), concanavalin-A (Con-A), or soluble S. enterica antigens (Se Ag) was measured
as change in absorbance of MTS at 490 nm (a). Apoptosis was measured as activation of caspases 3 and 7 in splenocytes from uninfected mice
(Mice), S. enterica-infected mice (Ctrl), or S. enterica-infected, probiotic-treated mice to LPS (LPS), concanavalin-A (Con-A), or soluble S. enterica
antigens (Se Ag), detected as relative fluorescence intensity (RFI) of caspase substrate, were compared (b). The asterisks indicate statistically
significant differences between control (Ctrl) and treated groups by ANOVA, P < 0.05
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caspase recruitment domain protein 10 (Card10), tumor
necrosis factor alpha (Tnf), and fas-associated death
domain protein (Fadd) mRNA expression, which are in-
volved in initial steps of the apoptosis activation cascade
and also reduction of mRNA expression of Casp2 and
Casp12, which are involved in the activation of enzymes
involved in apoptosis (Table 2). Some genes involved in
suppression of apoptosis cascade activation were also sup-
pressed, including: defender against cell death 1 (Dad1),
p21-activated kinase 7 (Pak7), v-akt murine thymoma viral
oncogene homolog 1 (Akt1), Bcl10, and bcl2-associated
agonist of cell death (Bad) (Table 2). These seemingly
contradictory findings illustrate the precise balance
needed in feedback regulation mechanisms for apoptosis
in antigen-activated lymphocytes.
Probiotic bacteria changed the tissue distribution of
cellular activation markers
In addition to mRNA expression effects of probiotic bac-
teria, tissue distributions of several proteins were investi-
gated. Immunohistochemical staining of MALT and
mesenteric lymph node tissues was used to trace the tis-
sue locations of cells with changes in production of
CD21, CD2, PTPRC, RELB, and TLR6 proteins within
the MALT tissues. Immunolocalization helped to inter-
pret the qPCR results in terms of probiotic effects on
host responses to S. enterica and these results will be
presented in the following narrative that includes the ob-
servations and discussion of their significance in the
context of T cells and antigen-presenting cells respond-
ing to S. enterica in the MALT and movement of these
cells between MALT and MLN.
The CD21 protein is expressed on B lymphocytes and
dendritic cells, which can be differentiated morpho-
logically in MALT and MLN. The germinal centers of
Peyer’s patches (Fig. 2a, b) and secondary follicles of
MLN (Fig. 2c, d) contained numerous cells with CD21
Table 2 Gene Expression Effects of Probiotic Bacteria on S.




B and T cell activation genesb
Cd2/Induces IFN-γ, interacts with PTPRC + 2.9
Cd21 (Cr2)/B cell complement receptor + 3.0
Hells/Helicase - Cell growth, DNA methylation + 2.5
Hsp90aa1/AKT signal transduction pathway, protein
chaperon
+ 2.3
Il4/TH-2 cytokine (IL-4) - 2.6
Il10/TH-2 cytokine (IL-10) + 3.6
Il12b/TH-1 cytokine (IL-12p40) - 2.7
Impdh/Cell growth + 2.5
Nkx2.3/Lymphocyte cellular differentiation + 2.3
Prkcd/B-cell signal transduction and apoptosis + 2.2
Prlr/Prolactin receptor + 2.1
Ptprc/(CD45/B220) cell growth/differentiation + 3.0
Tlr1/Proinflammatory receptor for microbes - 2.5
Tlr6/Proinflammatory receptor for microbes + 2.3
Vav1/T and B cell activation via JNK and P38 + 2.1
Wwp1/E3 ubiquitin protein ligase + 2.4
Zap70/T cell receptor cofactor - 2.4
Nf-κb signal transduction genesc
Bcl2/Anti-apoptotic signaling - 1.1
Bcl2l10/Pro-apoptotic, pro-inflammatory signaling - 1.8
Cflar/Pro-apoptotic signaling - 1.2
Egr1/B-cell receptor signaling - 2.1
Fasl/Intercellular signaling, pro-apoptotic - 3.3
Fos/Intracellular signaling, pro-apoptotic - 3.1
Icam1/Leukocyte movement, signaling - 2.3
Iκκa (Chuk)/Pro-inflammatory activator of NF-κB - 2.1
Irak2/Induces NFκB nuclear translocation + 2.3
Jun/(AP-1) B-cell and T-cell receptor signaling + 2.1
Mekk/(Map3k1) Pro-inflammatory - 2.2
Myd88/Pro-apoptotic and inflammatory adapter - 3.8
Nfkbia/Blocks NFκB nuclear translocation - 2.1
Relb/NFκB cofactor activation in B-cells - 3.0
Ripk1/Pro-inflammatory, apoptosis regulatory - 1.1
Rnf7/IκB ubiquitination – pro-apoptotic, pro-inflammatory - 3.8
Traf2/Pro-inflammatory, apoptosis regulatory - 1.7
Apoptosis genesd
Akt1/Anti-apoptotic - 2.1
Bad/Anti- apoptotic - 2.2
Card10/Proinflammatory via NFκB, pro-apoptotic - 4.3
Casp2/Pro-apoptotic - 2.3
Table 2 Gene Expression Effects of Probiotic Bacteria on S.
enterica-Challenged Mice (Fold Change in mRNA Expression vs.
Control) (Continued)
Casp12/Pro-apoptotic - 2.8
Dad1/Possible apoptosis inhibitor - 3.1
Fadd/Pro-apoptotic - 2.2
Pak7/Protein kinase induces proliferation/ anti-apoptotic - 4.2
Tnf/Pro-apoptotic cytokine - 2.4
aThe mean (n = 4/group) fold change in qRT-PCR threshold cycles (CT)
between tissue RNA samples amplified from probiotic-treated versus untreated
control mice were calculated as 2(−ΔΔCT), where ΔCT is the housekeeping gene-
normalized average CT and ΔΔCT is the ΔCT(treatment)- ΔCT(control). Positive values
indicate increased expression and negative values indicate reduced expression
bResults from Qiagen PAMM-053 Mouse T and B Cell Activation Array
cResults from Qiagen PAMM-025 Mouse NF-κB Array
dResults from Qiagen PAMM-012 Mouse Apoptosis Array
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Fig. 2 Immunohistochemical staining of CD21in Peyer’s Patches and MLN. The germinal centers of Peyer’s patches (Pp) (a, control mice; b,
probiotic-treated mice) and MLN (c, control mice; d, probiotic-treated mice) contained numerous cells with CD21 (arrows) that have lymphocyte
morphology. Images 10× magnification. There were no significant differences in optical density of stained cells in probiotic-treated Peyer’s
patches (Pp) and lamina propria (Lp) compared to control S. enterica-challenged Peyer’s patches and lamina propria by ANOVA, P < 0.05 (e)
a b c
d e f
Fig. 3 Immunohistochemical staining of CD2 in Peyer’s Patches and MLN. Peyer’s Patches (Pp) of S. enterica-infected mice were highly reactive
with heavy follicular CD2- staining (arrows), especially in probiotic-treated mice (a, control mice; b, probiotic-treated mice). There were no significant
differences in staining between control and treated Peyer’s patches or lamina propria (Lp) (c). CD2 staining of cortical and paracortical lymph node
tissue (d, control mice; e, probiotic-treated mice) in probiotic-treated Salmonella-infected mice were different than control mice. Images 10×
magnification. Statistically significant differences in staining of cortical and paracortical regions of the lymph nodes between control and probiotic-
treated mice are shown at the asterisk, P < 0.05 (f)
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that have lymphocyte morphology. Densitometry of the
Peyer’s patches stained for CD21 suggested no change
in the numbers of cells expressing this marker in the
probiotic-treated group, (P = 0.055) by ANOVA (Fig.
2e). The increased CD21 mRNA expression in Peyer’s
patches of the mice with probiotic treatment (Table 2)
did not appear to change the numbers of CD21-
producing cells in the Peyer’s patches.
Peyer’s patches of S. enterica-infected mice were highly
reactive with heavy follicular CD2- staining (Fig. 3a).
This is indicative of a strong migration of activated T
cells to the site. There was reduced diffuse CD2 staining
of cortical and paracortical lymph node tissue (Fig. 3e)
in probiotic-treated S. enterica-infected mice, which was
statistically significant between cortical and paracortical
regions of the lymph nodes (Fig. 3f ). These results are
consistent with reduced inflammatory response in the
probiotic-treated mice.
The infiltration of PTPRC-expressing cells in Peyer’s
Patches (Fig. 4a, b) and MLN (Fig. 4d, e) of probiotic
treated and control S. enterica-infected mice in the
two tissues appeared similar. Comparisons of staining
densities of the replicates in these tissues of both
treatment groups also showed no significant differ-
ence (Fig. 4c, f ).
Expression of TLR6 was investigated immunohisto-
chemically because its mRNA expression was increased
in the probiotic-treated mice. TLR6 was not strongly
stained in Peyer’s patches from probiotic-treated S.
enterica-infected mice (Fig. 5b). The amount of TLR6 in
cortical areas of probiotic-treated MLN (Fig. 5d), was
significantly reduced, compared with untreated S. enter-
ica-challenged mice (Fig. 5e).
RELB cortical staining was apparent in Peyer’s patches
of probiotic-treated S. enterica-infected mice (Fig. 6b).
Staining was also seen in MLN from the probiotic-treated
mice (Fig. 6e) but was not significantly different between
regions of the tissues or between treatments (Fig. 6c, f ).
Discussion
The concept of T cell depletion by early induction of a
strong inflammatory response by S. enterica has been
previously described [2, 3]. In the present study, we
observed recovery of T cell proliferative responses in
splenocytes from mice treated with the probiotic bacter-
ial blend prior to S. enterica infection, which is consist-
ent with the concept that T cell depletion was averted.
In a previous report, an immunosuppressive effect of S.
enterica infection was observed on splenic lymphoprolif-
erative responses in gnotobiotic BALB/c mice [5].
a b c
d e f
Fig. 4 PTPRC production shown by immunohistochemistry. Peyer’s patches (Pp) and lamina propria (Lp) (a, control mice; b, probiotic-treated
mice) appeared to have the same amount of PTPRC staining (arrows). There were no significant differences measured by densitometry (c). MLN
(d, control mice; e, probiotic-treated mice) of probiotic-treated and S. enterica-infected mice also showed similar amounts of PTPRC staining in
germinal centers. No significant differences in PTPRC staining between control and treated mice were confirmed by densitometry (f). PTPRC
staining is shown at the arrows
Wagner and Johnson BMC Microbiology  (2017) 17:77 Page 8 of 12
Treatment of the mice with probiotic bacteria prevented
the immunosuppressive effects. There are several im-
munosuppressive mechanisms used by virulent S. enter-
ica to evade host responses, including elimination of
high-avidity antigen-specific T cells [2], activation of
suppressive regulatory T cells [3], and phagolysosomal
escape in macrophages and dendritic cells [1, 7].
In the present study, the probiotic bacteria suppressed
basal and LPS-induced splenic lymphoproliferation. A
growing body of literature is reporting this characteristic
of probiotic lactobacilli with inhibition of LPS-stimulated
lymphocyte proliferation [8], inhibition of Concanavalin-
A-stimulated proliferation [9], and anti-CD3ε-stimulated
splenocyte proliferation [10]. It is consistent with the con-
cept that pathogen-induced lymphocyte clonal deletion
can be blocked by bacterial induction of mechanisms that
inhibit proliferation. Cell surface receptors for commensal
or probiotic bacteria may activate pathways that prevent
proliferation and apoptosis of lymphocytes.
Bacterial activation of a pathway that inhibits lympho-
cyte activation and apoptotic caspase activity most likely
occurs through the recognition of bacterial surface gly-
coproteins by TLR1, TLR2, or TLR6 on APC [11]. TLR4
(detects lipopolysaccharides-LPS) and TLR5 (detects
flagellin) are also involved in the T cell activation re-
sponse to S. enterica by APC [11]. In our present study,
gene expression profiling qRT-PCR panels and immuno-
histochemistry were used to observe changes in expres-
sion of genes associated with lymphocyte activation and
apoptosis and signal transduction from Toll-like recep-
tors through the NF-κB and MAPK signal transduction
pathways that showed evidence for a T cell-sparing effect
from the influence of probiotic bacteria. Activation and
signaling responses by lymphocytes are regulated by the
NF-κB transcription factor and signal transduction path-
way [12]. Some of the intracellular molecules that acti-
vate NF-κB include: CFLAR [13], CASP8 [13], conserved
helix-loop-helix ubiquitous kinase (CHUK/IκκA) [14],
RIPK1 [15], TRAF2 [15], and BCL10 [16].
Here we show evidence for a probiotic mechanism
that prevents S. enterica immune evasion by T cell dele-
tion through a mechanism of reduced inflammatory re-
sponse early during the infection in BALB/c mice. The
probiotic bacteria modulated expression of genes related
to inflammation and T cell apoptosis, including some of
the Toll-like receptors involved in S. enterica-induced
inflammation. In this present study, we observed in-
creased Tlr6 mRNA in MALT of probiotic-treated mice
b ca
ed
Fig. 5 Immunohistochemical staining of TLR6. Cells were stained for TLR6 (arrows) in Peyer’s Patches (a, control mice; b, probiotic-treated mice)
and MLN (c, control mice; d, probiotic-treated mice) from S. enterica-infected and probiotic-treated S. enterica-infected mice. The amount of TLR6
in cortical areas of probiotic-treated MLN was significantly reduced, P < 0.05 by ANOVA, compared with untreated S. enterica-challenged mice (e)
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compared with S. enterica-treated mice. This agrees with
evidence that probiotic Lactobacillus plantarum induced
Tlr6 mRNA expression in intestinal epithelial cells of
cyclophosphamide-suppressed mice [17]. We also ob-
served that there was not an increase in TLR6 expressing
cells in Peyer’s patches, suggesting a role for post-
transcriptional regulation of TLR6 on the surface of lym-
phocytes in our mice. It is possible that TLR2 and TLR6
heterodimer activation can be inhibited by probiotics
through activation of peptide regulators, as shown with
TLR6 transmembrane domain peptides in vitro [18]. The
latter paper suggested this inhibition is specific to TLR2,
but the work was in vitro and may not show how the
process may affect TLR2/TLR6 heterodimer surface ex-
pression in cells in vivo. Another possibility for this in the
present study is that the different microbiota used in the
human microbiota-associated mice versus the conven-
tional mice may not have supported the probiotic effect.
Since we saw probiotic bacteria could reverse the sup-
pression of splenic lymphocyte proliferation to S. enter-
ica antigens, we looked at changes in expression of
genes associated with T cell activation in mice treated
with probiotic bacteria. Initial contacts by intestinal epi-
thelial cells or professional phagocytes with S. enterica
surface molecules that have pathogen-associated molecu-
lar patterns activate receptors that initiate signal transduc-
tion within the cell. These signals initiate mRNA
transcription and protein synthesis of cytokines that are
secreted into the extracellular environment and recruit in-
flammatory cells. When dendritic cells encounter S. enter-
ica antigens in the intestinal tissues, they process the
antigens for presentation to lymphocytes and migrate to
MLN [19]. In the MLN, the dendritic cells activate
antigen-specific T cells that are selected by stromal cells
for expression of α4β7 integrin and CCR9, which is essen-
tial for their migration along a gradient of CCL25 and
other chemokines to the intestinal MALT [20–22].
Clues to the probiotic mechanism that blocks S. enter-
ica-induced immunosuppression might be seen in changes
of expression of genes involved in recruitment of immune
responses to the MALT and MLN of mice protected by
the bacteria from S. enterica infection. MLN are essential
for resistance to S. enterica infections, but are also the
sites of long term persistence of infections [1]. The MLN
hold S. enterica-infected dendritic cells and limit the
dissemination of the infection by arresting DC migration
[23]. Still, some of the bacteria can escape the MLN be-
cause host cell death can be induced by S. enterica, espe-
cially Serovar Typhimurium [1].
Some probiotic mechanisms do not involve immune and
inflammatory cell migration. For example, cell-free spent
media from probiotic Bifidobacterium bifidum inhibits
growth of S. enterica [24]. These authors suggest that Bifi-
dobacter-derived factors interfere with expression of S.
a b c
d e f
Fig. 6 Immunohistochemical staining of RELB. The Peyer’s patches and lamina propria (a, control mice; b, probiotic-treated mice) and MLN of
probiotic-treated S. enterica-infected mice (d, control mice; e, probiotic-treated mice) had RELB expressed in cells (arrows) with lymphocyte and
epithelial cell morphologies. There were no significant differences in staining of lamina propria (Lp) of control or probiotic-treated mice (c).
Staining in MLN from the probiotic-treated mice was not significantly different from controls, P < 0.05 by ANOVA (f)
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enterica virulence genes encoded on the Salmonella patho-
genicity islands 1 and 2. Some effects of commensal and
probiotic bacteria appear to occur at the mucosal surface in
epithelial cells. Some surface layer proteins of Lactobacillus
acidophilus inhibit CASP3 responses to Salmonella sp. in
IEC cell lines [25] thus, reducing apoptotic death and loss
of epithelial barrier functions to Salmonella sp. invasion.
Clearly, evidence exists for the combination of microbial
interactions for colonization resistance to S. enterica infec-
tions and influences on the innate and adaptive immune
responses can be attributed to probiotic bacteria.
Conclusions
Despite all the efforts of public health and agricultural pro-
grams to reduce acquisition of Salmonella sp. infections,
they persist as a major health issue. One reason for this is
the asymptomatic carrier state of some individuals who
have recovered from acute infections. Persistence of a
carrier state is facilitated by immune system evasion mech-
anisms inherent to the genus. Strains of bacteria in the
intestinal microbiota and found in probiotic products can
antagonize Salmonella sp. infections, perhaps by inhibition
of these inherent immune system evasion mechanisms. In
this study, the presence of probiotic bacteria in the intes-
tinal tracts of mice during S. enterica infections prevented
loss of splenocyte proliferation and decreased splenocyte
apoptosis. Gene expression data showed changes that
suggest lymphocyte activation, survival. And immune cell
homing functions were restored, This was related to an ap-
parent ability of the probiotic bacteria to limit exhaustive
lymphocyte proliferation and apoptosis. The migration of
lymphocytes and dendritic cells in intestinal mucosal tissues
was restored by the presence of the probiotic bacteria.
These results are consistent with the theory that S. enterica
induced clonal deletion of lymphocytes that was inhibited
by the presence of probiotic bacteria.
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